share_log

GeneDx to Participate in Upcoming Investor Conference

GeneDx to Participate in Upcoming Investor Conference

GeneDx將參加即將舉行的投資者會議
GeneDx Holdings ·  2024/11/22 13:00

STAMFORD, Conn.--(BUSINESS WIRE)--Nov. 22, 2024--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in the Piper Sandler 36th Annual Healthcare Conference from December 3-5 in New York City, NY. Management will participate in a fireside chat on Tuesday, December 3, 2024, at 1:00 p.m. ET.

康涅狄格州斯坦福--(商業線)--2024年11月22日--GeneDx(納斯達克:WGS),通過基因組洞察提供改善健康結果的領先者,今天宣佈公司管理層將參加派傑投資第36屆醫療保健年會,地點爲紐約市,紐約州,時間爲2024年12月3日至5日。管理層將於2024年12月3日星期二下午1:00參與火爐聊天。

Live and archived webcasts will be available on the "Events" section of the GeneDx investor relations website at ir.genedx.com/news-events/events.

現場直播和存檔網絡廣播將在GeneDx投資者關係網站ir.genedx.com/news-events/events的"活動"部分提供。

About GeneDx

關於GeneDx

At GeneDx (Nasdaq: WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world's largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. For more information, please visit genedx.com and connect with us on LinkedIn, X, Facebook, and Instagram.

在GeneDx(納斯達克:WGS),我們相信每個人都應該獲得個性化、有針對性的醫療保健,而這一切始於基因診斷。憑藉世界上最大的罕見疾病數據集之一,我們領先行業的外顯子組和基因組檢測將複雜的基因組數據轉化爲臨床答案,解鎖個性化健康計劃,加速藥物研發並提高衛生系統效率。如需更多信息,請訪問genedx.com,並在領英、X、Facebook和Instagram上與我們聯繫。

View source version on businesswire.com:

在businesswire.com上查看源版本:

Investor Relations:
investors@GeneDx.com

投資者關係:
investors@GeneDx.com

Media:
press@GeneDx.com

媒體:
press@GeneDx.com

Source: GeneDx

來源:GeneDx

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論